Involvement of Genetic Factors in Multiple Sclerosis.
作者信息
Ferrè Laura, Filippi Massimo, Esposito Federica
机构信息
Neurology Unit, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Neurorehabilitation Unit, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
出版信息
Front Cell Neurosci. 2020 Dec 1;14:612953. doi: 10.3389/fncel.2020.612953. eCollection 2020.
Abstract
摘要
相似文献
1
Involvement of Genetic Factors in Multiple Sclerosis.遗传因素在多发性硬化症中的作用
Front Cell Neurosci. 2020 Dec 1;14:612953. doi: 10.3389/fncel.2020.612953. eCollection 2020.
2
The relation between inflammation and neurodegeneration in multiple sclerosis brains.多发性硬化症患者大脑中炎症与神经退行性变之间的关系。
Brain. 2009 May;132(Pt 5):1175-89. doi: 10.1093/brain/awp070. Epub 2009 Mar 31.
3
Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis.多发性硬化症神经退行性变的已批准和新兴疾病修饰疗法。
Int J Mol Sci. 2020 Jun 17;21(12):4312. doi: 10.3390/ijms21124312.
4
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.新型口服钙蛋白酶抑制剂 SNJ-1945 对多发性硬化症小鼠模型免疫调节和神经退行性变的影响。
J Neurochem. 2014 Jul;130(2):268-79. doi: 10.1111/jnc.12659. Epub 2014 Feb 12.
5
Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis.线粒体在多发性硬化症神经退行性变中的作用
Biochemistry (Mosc). 2018 Jul;83(7):813-830. doi: 10.1134/S0006297918070052.
6
Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system.阿尔茨海默病和多发性硬化症之间的共享遗传位点：神经退行性变与免疫系统的交叉路口。
Neurobiol Dis. 2023 Jul;183:106174. doi: 10.1016/j.nbd.2023.106174. Epub 2023 Jun 5.
7
The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis.多发性硬化症中炎症与神经退行性变的时间和因果关系。
Mult Scler. 2020 Jul;26(8):876-886. doi: 10.1177/1352458519886943. Epub 2019 Nov 4.
8
The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.多发性硬化症之谜：炎症和神经退行性变导致异质性功能障碍和损伤。
Curr Opin Neurol. 2003 Jun;16(3):259-65. doi: 10.1097/01.wco.0000073925.19076.f2.
9
[Immunopathology of multiple sclerosis].[多发性硬化症的免疫病理学]
Medicina (B Aires). 2014;74(5):404-10.
10
Disease-specific molecular events in cortical multiple sclerosis lesions.皮质多发性硬化病变中的特定疾病分子事件。
Brain. 2013 Jun;136(Pt 6):1799-815. doi: 10.1093/brain/awt110. Epub 2013 May 17.
引用本文的文献
1
Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment.探索白细胞介素-6 rs1800795 G > C 单核苷酸多态性与爱泼斯坦-巴尔病毒相关多发性硬化症严重程度之间的联系：对认知障碍的潜在影响。
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05211-x.
2
The Potential of Transcranial Direct Current Stimulation (tDCS) in Improving Quality of Life in Patients with Multiple Sclerosis: A Review and Discussion of Mechanisms of Action.经颅直流电刺激（tDCS）改善多发性硬化症患者生活质量的潜力：作用机制的综述与探讨
J Clin Med. 2025 Jan 9;14(2):373. doi: 10.3390/jcm14020373.
3
Genes, Gene Loci, and Their Impacts on the Immune System in the Development of Multiple Sclerosis: A Systematic Review.基因、基因位点及其在多发性硬化症发展过程中对免疫系统的影响：一项系统综述。
Int J Mol Sci. 2024 Nov 30;25(23):12906. doi: 10.3390/ijms252312906.
4
The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'.炎症在神经系统疾病中的作用：多发性硬化症、阿尔茨海默病和帕金森病概述
Front Neurol. 2024 Oct 29;15:1439125. doi: 10.3389/fneur.2024.1439125. eCollection 2024.
5
The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study.父母近亲婚配和家族聚集与多发性硬化症发病的关系：病例对照研究。
Eur J Med Res. 2024 Oct 18;29(1):503. doi: 10.1186/s40001-024-02094-x.
6
Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes.线粒体动力学在神经退行性疾病中的作用：解析融合和分裂过程
Int J Mol Sci. 2023 Aug 22;24(17):13033. doi: 10.3390/ijms241713033.
7
Potentially toxic elements in the brains of people with multiple sclerosis.多发性硬化症患者大脑中的潜在有毒元素。
Sci Rep. 2023 Jan 12;13(1):655. doi: 10.1038/s41598-022-27169-9.
本文引用的文献
1
Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS.细胞类型特异性基因内相互作用揭示多发性硬化症中的少突胶质细胞机制。
Cell. 2020 Apr 16;181(2):382-395.e21. doi: 10.1016/j.cell.2020.03.002. Epub 2020 Apr 3.
2
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.多发性硬化症基因组图谱提示外周免疫细胞和小胶质细胞与易感性有关。
Science. 2019 Sep 27;365(6460). doi: 10.1126/science.aav7188.
3
Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.多发性硬化症患者携带炎症小体调节基因中极其罕见的遗传变异的负担增加。
Sci Rep. 2019 Jun 24;9(1):9171. doi: 10.1038/s41598-019-45598-x.
4
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.外显子组测序在多发性硬化症家族中鉴定出 12 个候选基因，并提名了疾病发生的生物学途径。
PLoS Genet. 2019 Jun 6;15(6):e1008180. doi: 10.1371/journal.pgen.1008180. eCollection 2019 Jun.
5
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.低频和罕见编码变异导致多发性硬化症风险增加。
Cell. 2018 Nov 29;175(6):1679-1687.e7. doi: 10.1016/j.cell.2018.09.049. Epub 2018 Oct 18.
6
Multiple Sclerosis Pathology.多发性硬化症病理学。
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):a028936. doi: 10.1101/cshperspect.a028936.
7
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci.醋酸格拉替雷治疗多发性硬化症的药物遗传学：全基因组关联研究确定的疾病风险位点的影响。
Pharmacogenomics. 2017 Nov;18(17):1563-1574. doi: 10.2217/pgs-2017-0058. Epub 2017 Nov 2.
8
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.多发性硬化症晚期临床试验队列中对考帕松高反应的药物遗传学特征。
Genome Med. 2017 May 31;9(1):50. doi: 10.1186/s13073-017-0436-y.
9
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.多发性硬化症患者对β-干扰素治疗的反应：一项全基因组关联研究。
Pharmacogenomics J. 2017 Jul;17(4):312-318. doi: 10.1038/tpj.2016.20. Epub 2016 Mar 22.
10
Multiple sclerosis prevalence in the United States commercially insured population.美国商业保险人群中的多发性硬化症患病率。
Neurology. 2016 Mar 15;86(11):1014-21. doi: 10.1212/WNL.0000000000002469. Epub 2016 Feb 17.
Zotero 插件